Prussian Blue (Radiogardase) in Nuclear Medicine: New Approaches to Treating Internal Radioactive Toxicity-Mechanisms and Efficacy in Radionuclide Contamination. Drug Discovery and Molecular Docking (DDMD), [S. l.], p. 106–122, 2026. DOI: 10.64474/3107-6688.Vol2.Issue1.8. Disponível em: https://ddmd.nknpub.com/1/article/view/23. Acesso em: 21 apr. 2026.